Early day motion tabled by primary sponsor Conal Gregory (Conservative), on Thursday, 31 October 1991, in the House of Commons. It is signed by 2 members in total.
PHARMACEUTICAL AWARD
That this House recognises the important contribution of the United Kingdom pharmaceutical industry to the health of the nation; notes that the highest award within that industry is the Prix Galien, which is conferred annually on the product `judged to have made the most significant overall contribution to patient care in terms of efficacy, safety and innovation'; and congratulates AMGEN Roche on receiving the 1991 United Kingdom Prix Galien for their product Neupogen, which reduces neutropenia, a potentially life threatening consequence of chemotherapy in cancer patients.
Secondary information
- Type
- Early day motion
- Reference
- 52
- Session
- 1991-92
- Subjects
- Amgen Roche
- Link
- View this Early day motion on www.parliament.uk
Librarians' tools
- Timestamp
- 2014-09-04 13:59:35 +0100
- URI
- http://data.parliament.uk/edms/5136
- In Indexing
- http://indexing.parliament.uk/Content/Edit/1?uri=http://data.parliament.uk/edms/5136
- In Solr
- https://search.parliament.uk/claw/solr/?id=http://data.parliament.uk/edms/5136